Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5
Open Access
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (37) , 35194-35200
- https://doi.org/10.1074/jbc.m105670200
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- CCR5, CXCR4, and CD4 Are Clustered and Closely Apposed on Microvilli of Human Macrophages and T CellsJournal of Virology, 2001
- The AIDS Epidemic — Considerations for the 21st CenturyNew England Journal of Medicine, 1999
- Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host diseaseJournal of Clinical Investigation, 1999
- Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4Science, 1999
- Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.Journal of Clinical Investigation, 1998
- Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent PathwaysThe Journal of Experimental Medicine, 1998
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 1996
- Isolation of a New Human Retrovirus from West African Patients with AIDSScience, 1986
- The Role of Mononuclear Phagocytes in HTLV-III/LAV InfectionScience, 1986